Amgen to announce data on obesity drug MariTide at healthcare conference [Yahoo! Finance]
Eli Lilly and Company (LLY)
Last eli lilly and company earnings: 4/23 06:25 am
Check Earnings Report
US:NYSE Investor Relations:
investor.lilly.com
Company Research
Source: Yahoo! Finance
prepares on ?Monday to unveil results from a mid-stage trial extension designed to show if ?the medication helps people maintain weight loss. The company will announce the latest findings - as well as results ?from a Phase 2 trial of the once-monthly injection in diabetes patients - at the J.P. Morgan Healthcare Conference in San Francisco. "Other people are clamoring to develop once-monthly or less frequent dose medicines, and we are unambiguously in the lead there," Jay Bradner, Amgen's head of ?research and development, told Reuters on ?Monday. Amgen said in June that MariTide helped overweight or obese patients shed up to 20% of their body weight in its 52-week Phase ?2 study. Most patients, however, experienced gastrointestinal side effects like vomiting and the company said future trials would start with a much lower dose that would increase over time. In the second part ?of the Phase 2 trial - aimed at assessing the drug's potential as a ?maintenance therapy - patients
Show less
Read more
Impact Snapshot
Event Time:
LLY
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
LLY alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
LLY alerts
High impacting Eli Lilly and Company news events
Weekly update
A roundup of the hottest topics
LLY
News
- ???????2026???Drugs to Watch??????????????????????????11???? [CNET News]CNET News
- Pfizer CEO plans for soaring consumer market for obesity drugs akin to Viagra [Yahoo! Finance]Yahoo! Finance
- What are GLP-3s? Meet the new generation of weight-loss drugs with three key ingredients [FOX News]FOX News
- This Healthcare Stock Could Be One of the Best Companies to Own in 2026 [Yahoo! Finance]Yahoo! Finance
- Can Eli Lilly and Company's (NYSE:LLY) ROE Continue To Surpass The Industry Average? [Yahoo! Finance]Yahoo! Finance
LLY
Earnings
- 10/30/25 - Beat
LLY
Sec Filings
- 1/8/26 - Form 4
- 1/6/26 - Form 3
- 1/6/26 - Form 4
- LLY's page on the SEC website